section name header

Pronunciation

a-mox-i-SILL-in/klav-yoo-LAN-ate

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: aminopenicillins beta lactamase inhibitors

Indications

REMS


Action

  • Binds to bacterial cell wall, causing cell death; spectrum of amoxicillin is broader than penicillin. Clavulanate resists action of beta-lactamase, an enzyme produced by bacteria that is capable of inactivating some penicillins.
Therapeutic effects:
  • Bactericidal action against susceptible bacteria.

Spectrum:

Pharmacokinetics

Absorption: Well absorbed from the duodenum (75–90%). More resistant to acid inactivation than other penicillins.

Distribution: Diffuses readily into most body tissues and fluids. Does not readily enter brain/CSF; CSF penetration is in the presence of inflamed meninges. Crosses the placenta and enters breast milk in small amounts.

Metabolism/Excretion: 70% excreted unchanged in the urine; 30% metabolized by the liver.

Half-Life: 1–1.3 hr.

Time/Action Profile

(peak blood levels)

ROUTEONSETPEAKDURATION
PO30 min1–2 hr8–12 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Most Infections (Dosing based on amoxicillin component)

Serious Infections and Respiratory Tract Infections

Recurrent/persistent acute otitis media due to Multidrug-resistant

Streptococcus pneumoniae,

H. influenzae,

or

M. catarrhalis

Otitis Media, Sinusitis, Lower Respiratory Tract Infections, Serious Infections

Less Serious Infections

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Augmentin, Augmentin ES

Canadian Brand Names

Clavulin

Pill Image

amoxicillin_195-9028.jpg

Code

NDC Code